About Alzheimer’s Disease clinical trials
Alzheimer’s disease clinical trials are designed to evaluate if new medications have potential to treat the various stages of Alzheimer’s disease. Treatments used in clinical trials for prodromal or early stage Alzheimer’s disease trials are engineered to delay progression, or possibly reverse cognitive decline. Medications used in clinical trials of moderate stage Alzheimer’s disease are often to help with disease management.
About the study medications
Northwest Clinical Research Center is partnering with pharmaceutical company sponsors to evaluate the effectiveness of several novel treatments for Alzheimer’s disease.
We are currently enrolling clinical trials looking for volunteers with early stage Alzheimer’s dementia. You can learn more about one of these trials at the following website https://www.athira.com/category/news-releases/
Studies are also being done to evaluate if new medications may improve behavior changes in Alzheimer’s disease. These trials are enrolling patients with moderate stage dementia who may become easily upset or irritable or may have personality changes.
None of this research can be done without the help of volunteers.
SYMPTOMS OF ALZHEIMER'S THAT MAY PREDISPOSE SOMEONE TO BEHAVIORAL OR PERSONALITY CHANGES
- Increased memory loss and confusion
- Problems recognizing family and friends
- Problems coping with new situations
- Hallucinations, delusions, and paranoia
- Difficulty completing tasks (complex tasks such as driving, shopping, or finances or activities of daily living such as getting dressed, bathing, toileting, or eating)
THE ROLE OF A CAREGIVER
For all of our studies for dementia, a study partner or caregiver is required. The role of a caregiver is vital for evaluating the study medication. They will be attending visits and communicating with study personnel to help the study team monitor symptoms such as memory impairment, functioning at home, and behavior. Without research volunteers and their family and friends, it would not be possible to evaluate if these new treatments for Alzheimer’s dementia maintain functioning as well as the quality of life for patients and caregivers. Compensation for your time and a travel stipend are available to those who qualify and elect to participate.
CLINICAL STUDY PARTICIPATION
Northwest Clinical Research Center is conducting multiple clinical research studies evaluating treatments to monitor memory and behavior in adults between the ages of 50 up to 90 with Alzheimer's disease.
NO COST STUDY
There is no cost to participate in the study. If they qualify for the study, the participant will receive the following:
- Medical evaluation.
- Investigational Medication or Device.
- Study Related Medical Care.
- Compensation up to $1,800.
- Complimentary transportation or a travel stipend.